Drugs / CTB-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01647893 | Jul → Nov 2012 | — | HLB Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTB-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01647893 ↗ |
| Route | Intravenous | “IV bolus or IV infusion” NCT01647893 ↗ |